SCMOM 2012_Equalix – Video

Posted: November 30, 2012 at 12:42 pm




SCMOM 2012_Equalix
Eqalix has received exclusive commercial licensing rights from three prominent institutions for several groundbreaking technologies in Regenerative Medicine which have the potential to revolutionize the unmet needs in multiple commercial and therapeutic applications. These technologies introduce the second generation of products into development and address previously unmet medical needs in the Regenerative Medicine space. Using these technologies, Eqalix plans to develop and commercialize (a) plant-protein based nano-fiber scaffold for use in wound healing and aesthetic dermatology; (b) small-diameter hybrid vessels that foster the creation of a functional endothelium (c) 3-Dimensional tissue scaffolds with adjustable properties for organ and tissue replacement and repair. http://www.eqalix.com Presenter: Joseph Connell, CEO, EqalixFrom:AllianceRegenMedViews:0 0ratingsTime:16:47More inScience Technology

View post:
SCMOM 2012_Equalix - Video

Related Posts

Comments are closed.

Archives